Published in Ann Dermatol on February 14, 2013
Economic Impact of Atopic Dermatitis in Korean Patients. Ann Dermatol (2015) 0.79
Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child (1970) 5.85
Chronic asthma and growth failure in children. Lancet (1976) 1.87
Short stature and delayed skeletal maturation in children with allergic disease. J Allergy Clin Immunol (1982) 1.58
Growth impairment in children with atopic eczema. J R Soc Med (1987) 1.52
The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol (1994) 1.42
Growth in atopic eczema: a controlled study by questionnaire. Arch Dis Child (1989) 1.32
Small intestinal permeability to sugars in patients with atopic eczema. Br J Dermatol (1984) 1.19
Failure to thrive owing to inappropriate diet free of gluten and cows' milk. Br Med J (Clin Res Ed) (1984) 1.15
Eczema and atopy in early childhood: low IgA plasma cell counts in the jejunal mucosa. Arch Dis Child (1981) 1.00
A case of growth retardation and cushing's syndrome due to excessive application of betamethasone-17-valerate ointment. Dermatologica (1974) 0.98
Adult height in patients with childhood onset atopic dermatitis. Arch Dis Child (1997) 0.95
The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol (2003) 0.92
Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol (1995) 0.91
Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr (2006) 0.91
Corticosteroids' effect on the height of atopic dermatitis patients: a controlled questionnaire study. Pediatr Dermatol (2009) 0.86
Natural history and clinical manifestations of atopic dermatitis. Clin Rev Allergy (1986) 0.81
Incidence of sleep disorders in children with presumed normal variant short stature. J Paediatr Child Health (2005) 0.80
Growth patterns of allergic children; a statistical study using the grid technique. J Allergy (1948) 0.80
The effect of calcipotriol on the expression of human beta defensin-2 and LL-37 in cultured human keratinocytes. Clin Dev Immunol (2010) 1.13
A combination trial of intradermal radiofrequency and hyaluronic acid filler for the treatment of nasolabial fold wrinkles: a pilot study. J Cosmet Laser Ther (2013) 1.11
Prevalence and risk factors for atopic dermatitis: a cross-sectional study of 6,453 Korean preschool children. Acta Derm Venereol (2012) 1.03
Development of multiple pigmented nevi within segmental nevus depigmentosus. J Korean Med Sci (2002) 1.02
Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis. J Korean Med Sci (2010) 0.98
Suppression of T cell activation by hirsutenone, isolated from the bark of Alnus japonica, and its therapeutic advantages for atopic dermatitis. Eur J Pharmacol (2009) 0.97
Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg (2005) 0.91
Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J Korean Med Sci (2005) 0.91
Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat (2008) 0.91
Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci (2012) 0.89
Thermography as a predictor of postherpetic neuralgia in acute herpes zoster patients: a preliminary study. Skin Res Technol (2011) 0.89
Appropriate timing for thyroidectomy scar treatment using a 1,550-nm fractional erbium-glass laser. Dermatol Surg (2013) 0.89
(-)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production. Arch Pharm Res (2004) 0.88
Atopic dermatitis-like skin lesions reduced by topical application and intraperitoneal injection of Hirsutenone in NC/Nga mice. Clin Dev Immunol (2010) 0.87
Amlodipine-associated bullous pemphigoid with erythema multiforme-like clinical features. Int J Dermatol (2011) 0.87
Letter: creating preoperative images of subungual glomus tumors. Dermatol Surg (2008) 0.87
Treatment of hypertrophic burn scars by combination laser-cision and pinhole method using a carbon dioxide laser. Lasers Surg Med (2014) 0.87
Thermographic Follow-up of a Mild Case of Herpes Zoster. Arch Dermatol (2010) 0.85
Case of multiple myeloma associated with extramedullary cutaneous plasmacytoma and pyoderma gangrenosum. Int J Dermatol (2006) 0.85
Letter: Platelet-rich plasma for treating male pattern baldness. Dermatol Surg (2012) 0.84
Cutaneous Serratia marcescens infection in an immunocompetent patient after filler injection. Acta Derm Venereol (2013) 0.83
The annual changes of clinical manifestation of androgenetic alopecia clinic in korean males and females: a outpatient-based study. Ann Dermatol (2013) 0.83
Effect of taxifolin glycoside on atopic dermatitis-like skin lesions in NC/Nga mice. Phytother Res (2010) 0.83
Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biol Pharm Bull (2010) 0.83
Genetic Polymorphism of FLG in Korean Ichthyosis Vulgaris Patients. Ann Dermatol (2011) 0.82
Could a growth spurt cause linear focal elastosis like striae distensae? Ann Dermatol (2012) 0.82
Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo. Int J Dermatol (2010) 0.82
Beta-catenin promoter polymorphism is associated with asthma risk in Korean subjects. Clin Biochem (2012) 0.82
Effect of topical application and intraperitoneal injection of oregonin on atopic dermatitis in NC/Nga mice. Exp Dermatol (2010) 0.82
Expression of neutrophil gelatinase-associated lipocalin in skin epidermis. J Invest Dermatol (2006) 0.82
Botulinum toxin for the treatment of refractory erythema and flushing of rosacea. Dermatology (2015) 0.82
Quercetin-3-O-(2″-galloyl)-α-l-rhamnopyranoside inhibits TNF-α-activated NF-κB-induced inflammatory mediator production by suppressing ERK activation. Int Immunopharmacol (2013) 0.81
Branch-shaped Cutaneous Hypopigmentation and Atrophy after Intralesional Triamcinolone Injection. Ann Dermatol (2011) 0.81
Letter: autologous fat grafting and platelet-rich plasma for treatment of facial contour defects. Dermatol Surg (2012) 0.81
Photodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetration. Dermatol Surg (2010) 0.81
Long-pulsed Nd:YAG laser treatment of warts: report on a series of 369 cases. J Korean Med Sci (2009) 0.81
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by phenolic compounds from roots of Rhododendron mucronulatum. Phytother Res (2011) 0.80
Posttraumatic lipogranuloma on the lower leg. J Dermatol (2012) 0.80
Diarylheptanoid hirsutenone prevents tumor necrosis factor-alpha-stimulated production of inflammatory mediators in human keratinocytes through NF-kappaB inhibition. Int Immunopharmacol (2009) 0.80
Effect of Alnus japonica extract on a model of atopic dermatitis in NC/Nga mice. J Ethnopharmacol (2010) 0.79
Facial Pores: Definition, Causes, and Treatment Options. Dermatol Surg (2016) 0.79
Tinea incognito in Korea and its risk factors: nine-year multicenter survey. J Korean Med Sci (2013) 0.79
The use of 1540 nm fractional photothermolysis for the treatment of acne scars in Asian skin: a pilot study. Photodermatol Photoimmunol Photomed (2009) 0.78
Aggravation of atopic dermatitis-like symptoms by consecutive low concentration of formaldehyde exposure in NC/Nga mice. Exp Dermatol (2013) 0.78
Hirsutenone inhibits lipopolysaccharide-activated NF-kappaB-induced inflammatory mediator production by suppressing Toll-like receptor 4 and ERK activation. Int Immunopharmacol (2010) 0.78
Combined treatment with a nonablative infrared device and hyaluronic acid filler does not have enhanced efficacy in treating nasolabial fold wrinkles. Dermatol Surg (2011) 0.78
A case of dermatofibroma of the upper lip. Ann Dermatol (2010) 0.78
3,4,5-tricaffeoylquinic Acid inhibits the lipopolysaccharide-stimulated production of inflammatory mediators in keratinocytes. Pharmacology (2012) 0.78
Clinical comparison of two hyaluronic acid-derived fillers in the treatment of nasolabial folds: Mesoglow® and IAL System®. Int J Dermatol (2012) 0.77
Parvovirus B19 infection associated with acute hepatitis in infant. Pediatr Infect Dis J (2009) 0.77
A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of PP-501-B in correction of nasolabial folds. Dermatol Surg (2015) 0.77
Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC/Nga mice. Exp Dermatol (2014) 0.77
Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in NC/Nga mice. Int J Nanomedicine (2011) 0.77
Taxifolin Glycoside Blocks Human ether-a-go-go Related Gene K(+) Channels. Korean J Physiol Pharmacol (2013) 0.77
3,4,5-Tricaffeoylquinic acid inhibits tumor necrosis factor-α-stimulated production of inflammatory mediators in keratinocytes via suppression of Akt- and NF-κB-pathways. Int Immunopharmacol (2011) 0.76
FCεRI gene promoter polymorphisms and total IgE levels in susceptibility to atopic dermatitis in Korea. J Korean Med Sci (2011) 0.76
The anti-oxidative and anti-inflammatory effects of caffeoyl derivatives from the roots of Aconitum koreanum R. RAYMOND. Biol Pharm Bull (2009) 0.76
Treatment of refractory discoid lupus erythematosus using 1,064-nm long-pulse neodymium-doped yttrium aluminum garnet laser. Dermatol Surg (2011) 0.75
Efficacy of intradermal radiofrequency combined with autologous platelet-rich plasma in striae distensae: a pilot study. Int J Dermatol (2012) 0.75